SCHEMBL7357140

SCHEMBL7357140

CCOC(=O)CC(C)N1CC(=O)N(Cc2ccccc2)c2ccc(CCc3cc(C#N)cs3)cc2C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.37
PKM P14618 2/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ITGB3 P05106 9/20 0.34
ITGA2B P08514 9/20 0.34
LMNA P02545 2/20 0.33
PTGDR2 Q9Y5Y4 2/20 0.33
TSHR P16473 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GABRA1 P14867 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
GABRA2 P47869 1/20 0.31
CASP1 P29466 1/20 0.31
CASP3 P42574 1/20 0.31
CASP7 P55210 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7359434 0.92 MAPT (0.36) MAPTPKMALDH1A1MAPK1NPSR1
SCHEMBL7328657 0.90 MAPT (0.40) MAPTPKMALDH1A1MAPK1NPSR1
SCHEMBL7363260 0.89 ITGB3 (0.34) MAPTALDH1A1ITGB3ITGA2BLMNA
SCHEMBL7355898 0.88 ITGB3 (0.43) MAPTITGB3ITGA2BLMNATSHR
SCHEMBL7361895 0.88 ITGB3 (0.34) MAPTITGB3ITGA2BLMNATSHR
SCHEMBL7362794 0.84 MAPT (0.36) MAPTPKMALDH1A1MAPK1NPSR1
SCHEMBL7330135 0.84 MAPT (0.40) MAPTPKMALDH1A1MAPK1NPSR1
SCHEMBL7328359 0.83 ITGB3 (0.43) MAPTPKMALDH1A1MAPK1NPSR1
SCHEMBL7357194 0.82 MEN1 (0.34) MAPTGABRA1GABRG2GABRB3GABRA5
SCHEMBL7354786 0.82 ITGB3 (0.36) MAPTALDH1A1ITGB3ITGA2BGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663166-A ANTICOAGULANTS OF 1,4-BENZODIAZEPINE-2,5-DIONE AND 2-BENZOAZEPINE-1,4-DIONE DERIVATIVES; PREVENTS FIBRINOGEN BINDING NECESSARY FOR PLATELET AGGREGATION; SIDE EFFECT REDUCTION, E.G. EXCESSIVE BLEEDING GENENTECH, INC. (US) 1997-09-02 US disclosed
US-5565449-A PLATELET AGGREGATION INHIBITORS GENENTECH, INC. (US) 1996-10-15 US disclosed
EP-0610334-B1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII B III A RECEPTOR GENENTECH INC (US) 1996-01-24 EP disclosed
US-5403836-A Anticoagulants GENENTECH, INC. (US) 1995-04-04 US disclosed
US-5250679-A Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor GENENTECH, INC. (US) 1993-10-05 US disclosed
WO-1993008174-A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPIIbIIIa RECEPTOR GENENTECH, INC. (US) 1993-04-29 WO disclosed